hVIVO (HVO) Competitors GBX 7.16 -0.29 (-3.89%) As of 12:21 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock HVO vs. CIR, BVXP, 4BB, TILS, VSN, SCLP, MPH, ORPH, HEMO, and IMMShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Circassia Group (CIR), Bioventix (BVXP), 4basebio (4BB), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), Hemogenyx Pharmaceuticals (HEMO), and ImmuPharma (IMM). These companies are all part of the "biotechnology" industry. hVIVO vs. Its Competitors Circassia Group Bioventix 4basebio Tiziana Life Sciences Verseon Scancell Mereo BioPharma Group plc (MPH.L) Open Orphan Hemogenyx Pharmaceuticals ImmuPharma hVIVO (LON:HVO) and Circassia Group (LON:CIR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment. Which has stronger earnings and valuation, HVO or CIR? hVIVO has higher revenue and earnings than Circassia Group. Circassia Group is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£51.28M0.96£17.84M£0.01929.87Circassia Group£27.90M0.00N/A£0.01N/A Do analysts prefer HVO or CIR? hVIVO currently has a consensus target price of GBX 23, indicating a potential upside of 221.23%. Given hVIVO's stronger consensus rating and higher possible upside, research analysts plainly believe hVIVO is more favorable than Circassia Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score hVIVO 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Circassia Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HVO or CIR more profitable? hVIVO has a net margin of 25.96% compared to Circassia Group's net margin of 0.00%. hVIVO's return on equity of 47.93% beat Circassia Group's return on equity.Company Net Margins Return on Equity Return on Assets hVIVO25.96% 47.93% 11.97% Circassia Group N/A N/A N/A Do insiders and institutionals have more ownership in HVO or CIR? 4.6% of hVIVO shares are owned by institutional investors. 4.4% of hVIVO shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer HVO or CIR? In the previous week, hVIVO had 13 more articles in the media than Circassia Group. MarketBeat recorded 13 mentions for hVIVO and 0 mentions for Circassia Group. hVIVO's average media sentiment score of 0.71 beat Circassia Group's score of 0.00 indicating that hVIVO is being referred to more favorably in the media. Company Overall Sentiment hVIVO Positive Circassia Group Neutral SummaryhVIVO beats Circassia Group on 11 of the 13 factors compared between the two stocks. Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£49.21M£224.15M£6.13B£2.58BDividend Yield2.88%3.81%5.73%5.32%P/E Ratio929.8799.5085.154,414.47Price / Sales0.965,903.80575.41100,817.41Price / Cash4.9413.1937.3927.90Price / Book1.2999.1912.398.24Net Income£17.84M-£90.99M£3.32B£5.89B7 Day Performance10.15%-0.32%-0.24%-0.07%1 Month Performance-23.42%6.04%9.56%2.36%1 Year Performance-75.73%669.41%71.67%139.25% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVO2.1436 of 5 starsGBX 7.16-3.9%GBX 23+221.2%-74.1%£49.21M£51.28M929.87N/AGap DownCIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,400-2.0%N/A-37.0%£125.40M£13.66M1,620.3112High Trading Volume4BB4basebio1.5558 of 5 starsGBX 800+3.2%GBX 1,600+100.0%-42.7%£123.88M£1.78M-808.08101Gap DownTILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpSCLPScancellN/AGBX 10+2.6%N/A-29.8%£103.78M£4.71M-793.6551MPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179HEMOHemogenyx PharmaceuticalsN/AGBX 1,235-4.3%N/A+86,670.3%£66.21MN/A-534.8214IMMImmuPharmaN/AGBX 11.70+3.5%N/A+413.0%£58.82MN/A-1,314.6113Gap Down Related Companies and Tools Related Companies CIR Competitors BVXP Competitors 4BB Competitors TILS Competitors VSN Competitors SCLP Competitors MPH Competitors ORPH Competitors HEMO Competitors IMM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HVO) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredWall St’s “AI Godfather” breaks his silenceWhats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredNvidia CEO’s Regret: ‘I Wish I Gave [Elon] More’…Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
